Plandaí Biotechnology, Inc. (PLPL)

Plandaí Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	May 22, 2026	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012
Market Capitalization	0	6	36	47	57	25
Market Cap Growth	-94.95%	-83.57%	-23.48%	-17.88%	131.20%	-
Enterprise Value	-	20	50	58	66	25
Last Close Price	0.00	0.03	0.23	0.37	0.52	0.23
PS Ratio	0.13	19.88	388.78	177.63	160.05	333.93
PB Ratio	0.00	-0.49	-4.32	-11.50	-16.50	-28.18
EV/Sales Ratio	-	67.42	533.63	218.32	184.33	336.86
Debt / Equity Ratio	-1.34	-1.32	-1.92	-3.19	-3.31	-7.75
Net Debt / Equity Ratio	-1.34	-1.32	-1.91	-3.15	-3.16	-7.75
Net Debt / EBITDA Ratio	-6.89	-6.10	-1.90	-2.84	-4.37	-1.79
Net Debt / FCF Ratio	-16.82	-14.58	-4.49	-3.90	-2.89	-1.00
Asset Turnover	0.05	0.04	0.01	0.03	0.05	0.03
Inventory Turnover	26.71	27.79	327.26	212.46	-	-
Quick Ratio	0.00	0.00	0.00	0.05	0.57	0.05
Current Ratio	0.01	0.01	0.02	0.21	0.57	0.05
Return on Assets (ROA)	-26.23%	-25.99%	-62.45%	-32.87%	-22.31%	-78.62%
Return on Capital Employed (ROCE)	27.60%	30.10%	132.30%	-79.70%	-33.50%	-64.00%
Earnings Yield	-9620.53%	-73.78%	-26.53%	-33.06%	-3.81%	-15.19%
FCF Yield	-2226.65%	-18.25%	-9.86%	-7.04%	-6.62%	-27.46%
Buyback Yield / Dilution	-35.33%	-27.17%	-19.33%	-3.45%	-15.13%	-26.74%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.